Dr. Jonas Adalsteinn Adalsteinsson, MD

Dr. Adalsteinsson practices at Icahn School Of Medicine At Mount Sinai - New York (E 98th St) in New York, New York.

Dr. Adalsteinsson's NPI, 1881190635, was assigned on April 2, 2018. Dr. Adalsteinsson holds New York license 325329.

Dr. Adalsteinsson's primary practice is Icahn School of Medicine at Mount Sinai - New York (E 98th St), at 5 E 98th St Fl 2 Fl 2, New York, NY 10029. The practice phone is (212) 241-9393.

Dr. Adalsteinsson's primary practice is Icahn School Of Medicine At Mount Sinai - New York (E 98th St) in New York, New York. The medical group on file is Mount Sinai Institute for Liver Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adalsteinsson practices. Vendor and product names are available with a free account.

Dermatology is Dr. Adalsteinsson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Adalsteinsson's licenses on file in 2 states: New York and Utah.

CMS data shows 480 Medicare services from Dr. Adalsteinsson across 9 procedure codes in 2024, for 243 Medicare patients. Medicare paid $36,794 for them. Every service was in an office.

CMS counts 243 Medicare patients who saw Dr. Adalsteinsson in 2024. The largest group is 75 to 84, with 96 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adalsteinsson's median patient age at 66, with 47% women.

In 2024, Dr. Adalsteinsson wrote 452 Medicare Part D claims for 146 patients. 83% of them were for generic drugs. CMS names the drug for 363 of them, across 13 drugs with 11 or more claims each, at $176,850 in total drug cost. In 2023, CMS named 356 claims across 9 drugs.

Dmand AI links 51 papers to Dr. Adalsteinsson, published from 2017 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Iceland, Skin Neoplasms and Carcinoma, Basal Cell. Dr. Adalsteinsson has published most often in J Am Acad Dermatol. Dr. Adalsteinsson's most frequent co-authors are Arni Kjalar Kristjansson, MD, Benjamin N. Ungar, MD and Hao Feng, MD.

CMS Open Payments shows 60 general payments to Dr. Adalsteinsson from 11 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $37,106.